Featured
Robert L. Dilley, MD, PhD, knows the value of research first-hand, and credits his leukemia survival to a clinical trial that saved his life… a trial that would not have even existed if not for robust investment into research. Dr. Dilley, a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute and Mass General Brigham in Boston, shares his journey in an article originally featured in Medpage Today.
Learn the most and least common biomarkers for leukemia and MDS, and what these biomarkers tell us, when Lucy Godley, MD, PhD, joins us for "Leukemia Genetics and Biomarkers" on May 5. In this webinar, Dr. Godley, with the Robert H. Lurie Cancer Center, Northwestern Medical Group, will help us understand the role of leukemia genetics and biomarkers in navigating your cancer journey and improving outcomes.
After surviving her own battle with ALL when she was 14, Amy pursued a medical career that allows her to help other children in their fight against cancer. Today, she is a pediatric oncology nurse in the same hospital where her diagnosis was made. “I tell all of my patients they’re going to be so proud of themselves when they come out of this.”
About us
Research grants
As the nation's largest nonprofit focused exclusively on funding leukemia research, our grants are accelerating the development of new and better treatments and an ultimate cure for leukemia.
Patient support
Through our patient-centered approach, access to leukemia experts, and nationwide partnerships, our support programs help patients and their loved ones navigate every step of the cancer journey.
Get involved
Help us achieve a world without leukemia by joining our community of donors, volunteers, and supporters. Explore our numerous donation options, join a fundraising event, or create your own fundraiser.
Our impact
